YU88204A - 1-oksa 3-aza-dibenzoazuleni kao inhibitori stvaranja faktora tumorske nekroze i međuproizvodi za njihovo pripremanje - Google Patents

1-oksa 3-aza-dibenzoazuleni kao inhibitori stvaranja faktora tumorske nekroze i međuproizvodi za njihovo pripremanje

Info

Publication number
YU88204A
YU88204A YU88204A YUP88204A YU88204A YU 88204 A YU88204 A YU 88204A YU 88204 A YU88204 A YU 88204A YU P88204 A YUP88204 A YU P88204A YU 88204 A YU88204 A YU 88204A
Authority
YU
Yugoslavia
Prior art keywords
production
aza
oxa
intermediates
necrosis factor
Prior art date
Application number
YU88204A
Other languages
English (en)
Inventor
Mladen Merćep
Milan MESIĆ
Dijana Pešić
Iva Benko
Original Assignee
PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o. filed Critical PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o.
Publication of YU88204A publication Critical patent/YU88204A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Predmetni pronalazak se odnosi na derivate iz klase 1-oksa-3-aza-dibenzoazulena, na njihove farmakološki prihvatljive soli i solvate, na procese i medjuproizvode za njihovo dobijanje, kao i na njihova antiinflamatorna dejstva, a naročito na inhibiciju stvaranja faktora - α tumorske nekroze (TNF-α) i inhibiciju stvaranja interleukina-1 (IL-1), kao i na njihovo analgetsko dejstvo.[The present invention relates to derivatives of 1-oxa-3-aza-dibenzoazulene class, to their pharmacologically acceptable salts and solvates, to processes and intermediates for the preparation thereof as well as to their antiinflammatory actions, especially to the inhibition of tumour necrosis factor-α (TNF-α) production and the inhibition of interleukin-1 (IL-1) production as well as to their analgetic action.
YU88204A 2002-04-10 2003-04-09 1-oksa 3-aza-dibenzoazuleni kao inhibitori stvaranja faktora tumorske nekroze i međuproizvodi za njihovo pripremanje YU88204A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HR20020304A HRP20020304B1 (en) 2002-04-10 2002-04-10 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the production thereof

Publications (1)

Publication Number Publication Date
YU88204A true YU88204A (sh) 2006-08-17

Family

ID=28686902

Family Applications (1)

Application Number Title Priority Date Filing Date
YU88204A YU88204A (sh) 2002-04-10 2003-04-09 1-oksa 3-aza-dibenzoazuleni kao inhibitori stvaranja faktora tumorske nekroze i međuproizvodi za njihovo pripremanje

Country Status (23)

Country Link
US (1) US7232815B2 (sh)
EP (1) EP1492797B1 (sh)
JP (1) JP2005529867A (sh)
CN (1) CN1649878A (sh)
AT (1) ATE320434T1 (sh)
AU (1) AU2003259960A1 (sh)
BR (1) BR0309101A (sh)
CA (1) CA2481463A1 (sh)
DE (1) DE60304047T2 (sh)
DK (1) DK1492797T3 (sh)
ES (1) ES2260636T3 (sh)
HR (1) HRP20020304B1 (sh)
IL (1) IL164397A0 (sh)
IS (1) IS7473A (sh)
MX (1) MXPA04009944A (sh)
NO (1) NO20044507L (sh)
NZ (1) NZ535621A (sh)
PL (1) PL372456A1 (sh)
PT (1) PT1492797E (sh)
RU (1) RU2323222C2 (sh)
UA (1) UA79276C2 (sh)
WO (1) WO2003084964A1 (sh)
YU (1) YU88204A (sh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20020304B1 (en) * 2002-04-10 2008-04-30 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the production thereof
DE10256416A1 (de) * 2002-12-02 2004-06-09 Basf Ag Feste Pigmentzubereitungen, enthaltend Pigmentderivate und oberflächenaktive Additive
HRP20030959A2 (sh) * 2003-11-21 2005-10-31 Pliva-Istra�iva�ki institut d.o.o.
WO2006075255A2 (en) * 2005-01-13 2006-07-20 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Anti-inflamatory macrolide conjugates

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1340637A (en) * 1971-02-05 1973-12-12 Richardson Merrell Spa Dibenzocycloheptadioxolan derivatives
US3711489A (en) * 1971-03-31 1973-01-16 Pfizer Certain 8,9-dihydro(3,4,7,8)cycloocta(1,2-d)imidazoles
CA967573A (en) 1972-12-22 1975-05-13 Joseph G. Lombardino Tetracyclic anti-inflammatory agents
US4198421A (en) * 1978-11-30 1980-04-15 E. I. Du Pont De Nemours And Company Antiinflammatory 2-substituted-dibenzo[2,3:6,7]oxepino[4,5-d]imidazoles
HRP20000310A2 (en) * 2000-05-17 2002-02-28 Pliva Farmaceutska Ind Dioniko New dibenzoazulene compounds as tumor necrosis factor inhibitors
HRP20020303B8 (en) * 2002-04-10 2009-03-31 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. Benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
HRP20020304B1 (en) * 2002-04-10 2008-04-30 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the production thereof
US20050131056A1 (en) * 2002-04-10 2005-06-16 Pliva-Istrazivacki Institut D.O.O. 2- thia-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
HRP20020305A8 (en) * 2002-04-10 2009-03-31 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
HRP20020441A2 (en) * 2002-05-21 2003-12-31 Pliva D D 1-oxa-dibenzoazulen as inhibitor of production of tumor necrosis factors and intermediate for preparation thereof
HRP20020440B1 (en) * 2002-05-21 2008-02-29 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. 1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
HRP20020453A2 (en) * 2002-05-23 2003-12-31 Pliva D D 1,3-diaza-dibenzoazulen as inhibitor of production of tumor necrosis factors and intermediate for preparation thereof
HRP20020451A2 (en) * 2002-05-23 2003-12-31 Pliva D D 1-tia-3-aza-dibenzoazulen as inhibitor of production of tumor necrosis factors and intermediates for preparation thereof
HRP20030160A2 (en) * 2003-03-06 2005-04-30 Pliva-Istra�iva�ki institut d.o.o. 1-thiadibenzoazulene derivatives and biological action thereof
HRP20030885A2 (en) * 2003-11-03 2005-08-31 Pliva-Istra�iva�ki institut d.o.o. USE OF 2-THIA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYYTEM DISEASES AND DISORDERS

Also Published As

Publication number Publication date
CN1649878A (zh) 2005-08-03
MXPA04009944A (es) 2005-09-30
CA2481463A1 (en) 2003-10-16
PT1492797E (pt) 2006-07-31
ES2260636T3 (es) 2006-11-01
RU2004132867A (ru) 2005-05-10
DK1492797T3 (da) 2006-07-17
ATE320434T1 (de) 2006-04-15
PL372456A1 (en) 2005-07-25
UA79276C2 (en) 2007-06-11
NO20044507L (no) 2004-11-09
US7232815B2 (en) 2007-06-19
EP1492797B1 (en) 2006-03-15
HRP20020304B1 (en) 2008-04-30
IL164397A0 (en) 2005-12-18
US20050148576A1 (en) 2005-07-07
HRP20020304A2 (en) 2004-06-30
DE60304047D1 (de) 2006-05-11
AU2003259960A1 (en) 2003-10-20
IS7473A (is) 2004-09-27
EP1492797A1 (en) 2005-01-05
BR0309101A (pt) 2005-02-09
NZ535621A (en) 2006-03-31
RU2323222C2 (ru) 2008-04-27
WO2003084964A1 (en) 2003-10-16
DE60304047T2 (de) 2006-11-09
JP2005529867A (ja) 2005-10-06

Similar Documents

Publication Publication Date Title
AU2003224923A1 (en) Heterocyclic amide derivatives as cytokine inhibitors
ATE399175T1 (de) Hemmstoffe der urokinase, ihre herstellung und verwendung
WO2003099823A3 (en) 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
IL164395A0 (en) 1-Or-3-thia-benzonaphthoazulees as inhibitors of tumour necrosis factor production and intermediatesfor the preparation thereof
CY1105036T1 (el) 2-θεια-διβενζοαζουλενια ως αναστολεις της παραγωγης του παραγοντα νεκρωσης ογκων και ενδιαμεσα για την παρασκευη αυτων
MY136938A (en) New process for the synthesis of perindopril and its pharmaceutically acceptable salts
RS100004A (en) 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
YU88204A (sh) 1-oksa 3-aza-dibenzoazuleni kao inhibitori stvaranja faktora tumorske nekroze i međuproizvodi za njihovo pripremanje
RS99404A (en) 1-oxa-dibenzoazulenes as inhibitors of tumour necrosis facto production and intermediates for the preparation thereof
RS100204A (en) 1,2-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
MY136989A (en) New process for the synthesis of perindopril and pharmaceutically acceptable salts thereof